Increased expression of genes induced by IL-17A in keratinocytes and TCR genes, including genes previously determined to be a part of the PSTR or present as a psoriasis molecular scar (Tian et al, 2012), was more efficiently normalized by guselkumab than by ADA at all time points assessed (Figure 4). The gene discussed is IL17A; the disease is psoriasis.